[1]
Khan, K. 2025. Clinical Evaluation of Pioglitazone’s Impact on Insulin Resistance and Blood Pressure in Type 2 Diabetic Patients Undergoing Hemodialysis. International Journal of Medical and Biomedical Studies. 9, 1 (Jan. 2025), 241–246. DOI:https://doi.org/10.32553/ijmbs.v9i1.3063.